Europe spent this week supplying the hard parts. Lithography for someone else's quantum computer, clinical trial labs for an American buyer, battlefield robots for a company that redomiciled to Texas.
The component work is world class. The question is who ends up holding the company that sells it.
Two exceptions. A Belgian institute and a Swedish lab both published results this week that nobody else can currently match.
Lead
ASML Lends Its Lithography to a Canadian Quantum Company
ASML announced on September 10 that it will work with Xanadu, the Toronto photonic quantum computing company, on whether advanced lithography can cut optical losses in photonic quantum processors. The work targets pattern fidelity and line edge roughness, which together decide how much light survives a trip through an integrated photonic circuit.
Loss is the binding constraint on photonic quantum computing. A fault-tolerant photonic machine needs waveguides good enough that photons reach the end of the chip, and that is a patterning problem before it is a physics problem.
The Netherlands has its own integrated photonics quantum effort in Quix, based in Enschede. ASML choosing to run the experiment with a Canadian company first says something about which quantum programmes have the scale to absorb what its machines can do.
Biotech & Life Sciences
Pharvaris Cuts Angioedema Attacks by 83% With a Pill
Pharvaris, based in Leiden, reported topline results from its CHAPTER-3 pivotal trial on September 8. The oral extended-release form of deucrictibant cut monthly hereditary angioedema attacks by 83% against placebo over 24 weeks, rising to 87% in patients with type 1 or type 2 disease.
Every key secondary endpoint cleared significance, including a 23.53 point gain on the Angioedema Quality of Life score. No treatment-related serious adverse events were reported.
Prophylaxis for this condition currently means injections. Pharvaris is filing for marketing authorisation from the first half of 2027 and is running the programme itself rather than licensing it to a larger partner, which is the harder route and the one that keeps the value in Leiden.
(BioSpace)
Labcorp Buys Germany's Clinical Trial Lab Capacity
Labcorp announced on September 8 that it has acquired MLM Medical Labs, a central and specialty laboratory group with dual headquarters in Mönchengladbach and Memphis. The seller was Great Point Partners, and terms were not disclosed.
MLM has run biomarker and specialty testing for multinational trials since 1993. The purchase makes Labcorp the only central lab provider with wholly owned sites across four continents.
The EU Biotech Act is built on the premise that faster trial approvals will pull more clinical work into Europe. The infrastructure that actually processes those samples is consolidating under American ownership while the legislation is still in trilogue.
(Labcorp)
Quantum & Photonics
Chalmers Makes Bosonic Gates a Thousand Times Faster
Lei Du, Tangyou Huang and Lingzhen Guo, working across Chalmers University of Technology and Tianjin University, published a method in Physical Review Letters that completes quantum operations on bosonic states inside a single driving cycle. The previous approach needed thousands.
The technique combines quantum lattice gates with Floquet control on ordinary superconducting circuits, so it does not require new hardware.
Gate duration is the exposure window. Every cycle a bosonic state stays in play is time for electrical noise or a cosmic ray to corrupt it, which makes a speedup of this size an error-correction result rather than a benchmark one.
Space
BepiColombo Drops the Module That Carried It for Eight Years
ESA confirmed on September 7 that BepiColombo's Mercury Transfer Module separated cleanly from the spacecraft stack on September 3 at 15:49 CEST, 200 million kilometres from Earth. Confirmation took nearly two hours to arrive.
The module spent eight years and 9.9 billion kilometres pushing the stack through nine planetary flybys on four ion thrusters before its propulsion was switched off in June.
Orbit insertion for the Mercury Planetary Orbiter is set for November 21, with the Japanese Mio orbiter separating in early December and science starting in April 2027. This will be the first mission to put two spacecraft around Mercury, and Europe built the half that has to survive the approach.
(ESA)
Robotics & Automation
Universal Robots Takes a Chinese Rival to the Unified Patent Court
Teradyne Robotics filed suit against JAKA Robotics GmbH, the German arm of the Chinese cobot maker, in the Unified Patent Court's Copenhagen division on August 24. The case surfaced publicly on September 10.
Three Universal Robots patents with March 2006 priority dates are at issue, covering touchscreen programming with 3D representations, a solenoid and ratchet joint brake, and joint construction. The complaint names a broad range of JAKA cobots sold in Europe without yet mapping models to claims.
Universal Robots has shipped more than 100,000 arms since 2005 and this is its second European action against a Chinese competitor this year. The UPC is the instrument Europe built for exactly this, and Denmark is now testing whether it works fast enough to matter against price competition.
Ukraine's Ground Robot Consolidation Runs Through Austin
Swarmer, a Ukrainian-founded drone autonomy company now headquartered in Austin and chaired by Erik Prince, agreed on September 10 to acquire Kyiv-based Ratel Robotics for up to $224 million in cash, stock and earnouts. Ratel builds uncrewed ground vehicles for logistics, casualty evacuation, de-mining and strike work, and took about 37% of Ukraine's UGV spending between January and April this year.
Ratel signed $86 million in contracts during 2026. Its 300 staff join roughly 200 at Swarmer, whose software has run more than 100,000 combat missions since April 2024 and can coordinate up to 690 drones in one swarm.
Ukraine has Europe's only continuously battle-tested robotics industry, and it is now consolidating under a US-domiciled holding company. European defence funds have spent two years talking about access to that expertise while someone else bought it.
Semiconductors
Imec Packs 3.8 Million Josephson Junctions Into a Square Centimetre
Imec presented a three-metal-level superconducting circuit built on niobium titanium nitride at the Applied Superconducting Conference, announced September 8. Junction diameters reach 150 nanometres and design density reaches 3.8 million junctions per square centimetre, both firsts for the material.
Routing wires scaled to 30 nanometres, roughly ten times finer than conventional niobium allows, and the whole process runs on 300 millimetre wafers.
Superconducting logic has always been a wiring problem rather than a physics one. Leuven now holds a 300 millimetre platform for it and is offering joint development to industry, which puts a Belgian institute at the front of the queue for whoever builds the next generation of energy-constrained supercomputers.
(imec)
One to Watch
A Delft Pocketqube Goes Looking for Amino Acids in Early 2027
TU Delft will fly a silicon nitride photonic sensor built by Lionix International, the Enschede photonics company, on a pocketqube satellite in early 2027. The mission, LMCOOL, tests whether an asymmetric Mach-Zehnder interferometer can identify amino acids by reading tiny shifts in the refractive index of a liquid.
The chip descends from a life marker instrument Lionix developed for ESA's ExoMars programme two decades ago. The same Triplex platform now underpins biomedical diagnostics at Surfix.
Watch the launch window and the first calibration data. If the instrument works in orbit, Europe has a flight-qualified path toward the ocean world missions to Enceladus and Europa that are currently theoretical.